To me trial results reflect the pipeline, not the company
To me trial results reflect the pipeline, not the company name.
Of course Leo didn’t say the real purpose was to force NS to cover in the PR. I suggest you to read the filing on how much Leo spent for lawyer fees and website redesign. If the real purpose was just to change the name, it would be irresponsible for Leo to dilute the stock at shareholders’ expense when the SP was low.
Sullivan has shown he’s a very knowledgeable lawyer in defending CTIX and I’m grateful Leo hired him. He must have advised Leo on changing the name/CUSIP # to expose NS positions.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Vishay Intertechnology's Quarterly Dividend Announcement Vishay Intertechnology, Inc. (NYSE: VSH), a global leader in the manufacturing of discrete semiconductors and passive components, has recently made headlines by declaring a quarterly dividend. This announcement marks a significant moment for the company and its stakeholders as it reflects the steady financial health...
Continue Reading
Most discussions about recession-resistant business categories focus on the obvious choices: healthcare, essential retail, waste management, and food. What rarely comes up, despite being one of the cleaner examples of a service with demand that genuinely does not shrink during economic downturns, is commercial energy management. Specifically, the energy brokerage model is...
Continue Reading
Stephens Upgrades Guaranty Bancshares' Price Target Recently, Stephens announced an increase in its target price for Guaranty Bancshares, Inc. (NYSE: GNTY) to $40.00. This updated estimation is an advancement from the previous target of $38.00. The positive adjustment comes after the company reported strong third-quarter earnings per share (EPS), which exceeded analysts'...
Continue Reading
Lightwave Logic's Upcoming Special Call Announcement Lightwave Logic, Inc. (NASDAQ: LWLG) has exciting news to share as it prepares to host a special call on March 13, 2025. This event aims to shed light on the industry applications of electro-optic polymers, the company’s competitive positioning, and its strategic approach to market penetration. What to Expect from the...
Continue Reading
Innovative Partnership Between ONCare Alliance and Ovation.io The ONCare Alliance and Ovation.io have embarked on an exciting collaboration to develop a multi-omics database and biobank aimed at accelerating biomarker discovery in the oncology field. This partnership combines the expertise of 32 independent oncology practices represented by ONCare with Ovation.io, a...
Continue Reading
